A Maternally Sequestered, Biopolymer‐Stabilized Vascular Endothelial Growth Factor (VEGF) Chimera for Treatment of Preeclampsia

A Maternally Sequestered, Biopolymer‐Stabilized Vascular Endothelial Growth Factor (VEGF) Chimera for Treatment of Preeclampsia

BackgroundPreeclampsia is a hypertensive syndrome that complicates 3% to 5% of pregnancies in the United States. Preeclampsia originates from an improperly vascularized and ischemic placenta that releases factors that drive systemic pathophysiology. One of these factors, soluble fms‐like tyrosine ki...

Full description

Bibliographic Details
Main Authors: Omar C. Logue, Fakhri Mahdi, Heather Chapman, Eric M. George, Gene L. Bidwell
Format: Article
Language:English
Published: Wiley 2017-12-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
elastin‐like polypeptide
maternally sequestered drug delivery
preeclampsia/pregnancy
soluble fms‐like tyrosine kinase‐1
therapy
vascular endothelial growth factor
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.117.007216

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.117.007216

Similar Items